Development of Procedural Protocols for Botulinum Toxin 'Botulax'

Hugel Co., Ltd. announced that it will engage in a year-long collaboration with the Korean Society for Anti-Aging Dermatology (KAAD) to establish global standards for botulinum toxin procedures and enhance training for medical professionals.


On March 6, 2026, Hugel held the 'Hugel X Korean Society for Anti-Aging Dermatology Academic Collaboration Kickoff Meeting' at the Westin Seoul Parnas in Gangnam-gu, Seoul. The company stated on March 9 that during the meeting, academic discussions were held and future directions were shared regarding the development of procedural protocols for its botulinum toxin product 'Botulax' (export name: Letibot), as well as the implementation of global webinars.

They are taking a commemorative photo at the ‘Hugel X Korean Society for Anti-Aging Dermatology Academic Collaboration Kickoff Meeting’ held on the 6th at The Westin Seoul Parnas in Gangnam-gu, Seoul. Hugel

They are taking a commemorative photo at the ‘Hugel X Korean Society for Anti-Aging Dermatology Academic Collaboration Kickoff Meeting’ held on the 6th at The Westin Seoul Parnas in Gangnam-gu, Seoul. Hugel

View original image

The Korean Society for Anti-Aging Dermatology is a leading professional academic organization in Korea specializing in dermatology and anti-aging. The meeting was attended by 13 key executives from the society, including President Kwangho Han, as well as Hugel CEO Doohyun Jang, Vice President Seungwook Ji, and employees from the marketing, medical, and domestic business divisions.


Both parties agreed to hold a total of five global webinars, which will be conducted every other month from April to December this year. Each session will consist of theoretical lectures, live demonstrations, and Q&A segments. Real-time subtitles in English and Chinese will be provided for the convenience of medical professionals worldwide.


Kwangho Han, President of the Korean Society for Anti-Aging Dermatology, stated, "We are pleased to establish standardized procedural guidelines for botulinum toxin in partnership with Hugel, a leader in K-Aesthetics, and to effectively disseminate them. We are also delighted to offer professional educational content that provides practical support to medical professionals both in Korea and abroad."



Doohyun Jang, CEO of Hugel, said, "As an industry-leading company, Hugel is committed not only to product quality but also to engaging in various communication activities to earn the trust of medical professionals worldwide. We will continue to work with the Korean Society for Anti-Aging Dermatology to strengthen the academic standing and global competitiveness of Korea's medical aesthetics industry."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing